Plasma Fractionation Market by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Hematology, Critical Care, Rheumatology, Pulmonology), End User (Hospitals & Clinics) - Global Forecast to 2025

血漿分画の世界市場予測(〜2025):製品別(IVIG、アルブミン、第VIII因子、フォンウィルブランド因子、PCC、プロテアーゼ阻害剤)、用途別(免疫学、血液学、クリティカルケア、リウマチ学、呼吸器学)、エンドユーザー別(病院、診療所)

◆タイトル:Plasma Fractionation Market by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Hematology, Critical Care, Rheumatology, Pulmonology), End User (Hospitals & Clinics) - Global Forecast to 2025
◆商品コード:BT 3042
◆調査・発行会社:MarketsandMarkets
◆発行日:2020年9月10日
◆ページ数:269
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥519,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥698,250見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥855,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

Marketsandmarkets社は血漿分画の世界市場が2020年286億ドルから2025年395億ドルまで、年平均6.7%成長すると予測しています。本調査レポートでは、血漿分画の世界市場を広く調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、市場インサイト、製品別(免疫グロブリン、凝固因子濃縮物、アルブミン、プロテアーゼ阻害剤、その他)分析、用途別(神経学、免疫学、血液学、クリティカルケア、呼吸器学)分析、エンドユーザー別(病院・クリニック、臨床研究所、アカデミックインスティテュート)分析、地域別分析、競争状況、企業評価・情報などをまとめております。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・市場インサイト
・血漿分画の世界市場規模:製品別(免疫グロブリン、凝固因子濃縮物、アルブミン、プロテアーゼ阻害剤、その他)
・血漿分画の世界市場規模:用途別(神経学、免疫学、血液学、クリティカルケア、呼吸器学)
・血漿分画の世界市場規模:エンドユーザー別(病院・クリニック、臨床研究所、アカデミックインスティテュート)
・血漿分画の世界市場規模:地域別
・競争状況
・企業評価・情報

“Growing use of immunoglobulins in various therapeutic areas, increase in plasma collection (and the number of plasma collection centers), and the growing prevalence of respiratory diseases and alpha-1-antitrypsin deficiency (AATD) is expected to drive the overall growth of the plasma fractionation market.”
The global plasma fractionation market size is projected to reach USD 39.5 billion by 2025 from USD 28.6 billion in 2020, at a CAGR of 6.7% during the forecast period. Growth in the plasma fractionation market is primarily driven by factors such as growing use of immunoglobulins in various therapeutic areas, increase in plasma collection (and the number of plasma collection centers), rising geriatric population, and the growing prevalence of respiratory diseases and alpha-1-antitrypsin deficiency (AATD). However, the high cost of plasma products, limited reimbursements, and the emergence of recombinant alternatives are expected to restrain the growth of this market to a certain extent during the forecast period.

“The hospitals and clinics segment is expected to dominate the market during the forecast period.”
Based on end user, the plasma fractionation market is segmented into hospitals and clinics, clinical research laboratories, and academic institutes. In 2019, the hospitals and clinics segment accounted for the largest share of the global plasma fractionation market. The large share of this segment is attributed to the increasing adoption of plasma products in the treatment of various diseases, large patient pool treated in hospitals, and the increasing number of hospitals and clinics across the globe.

“The pulmonology application segment will witness the highest growth in the plasma fractionation market.”
Based on application, the plasma fractionation market is segmented into neurology, immunology, hematology, critical care, pulmonology, hemato-oncology, rheumatology, and other applications. In 2019, the pulmonology segment is expected to register the highest CAGR during the forecast period. Growth in this market segment is driven largely by the rising prevalence of alpha-1 antitrypsin deficiency and chronic obstructive pulmonary disease (copd).

“North America will dominate the market during the forecast period.”
Geographically, the plasma fractionation market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest share of the plasma fractionation market, followed by Europe and the Asia Pacific. The large share of North America in the global market is attributed to the growing use of immunoglobulins in various therapeutic areas, growing geriatric population, and the increasing prevalence of respiratory diseases and AATD. The primary interviews conducted for this report can be categorized as follows:
• By Company Type – Tier 1: 37%, Tier 2: 23%, and Tier 3: 40%
• By Designation – C-level: 32%, D-level: 26%, and Others: 42%
• By Region – North America: 35%, Europe: 25%, Asia Pacific: 20%, Latin America: 12%, and the Middle East and Africa: 8%
List of Companies Profiled in the Report
• CSL (Australia)
• Grifols (Spain)
• Shire (Ireland)
• Octapharma (Switzerland)
• Kedrion (Italy)
• LFB (France)
• Biotest (Germany)
• Sanquin (Netherlands)
• China Biologic Products (UK)
• Bio Products Laboratory (UK)
• Japan Blood Products Organization (Japan)
• Green Cross Corporation (South Korea)
• Shanghai RAAS Blood Products (China)
• Emergent BioSolutions (US)
• Intas Biopharmaceuticals (India)
• Bharat Serums and Vaccines Limited (India)
• SK Plasma (Republic of Korea)
• Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. (China)
• KabaFusion (US)
• Centurion Pharma (Turkey)
Research Coverage:
This report provides a detailed picture of the global plasma fractionation market. It aims at estimating the size and future growth potential of the market across different segments, such as product, application, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total plasma fractionation market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on plasma fractionation offered by the top 25 players in the plasma fractionation market. The report analyses the plasma fractionation market by product, application, end user, and region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various plasma fractionation across key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the plasma fractionation market.
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the plasma fractionation market.

【レポートの目次】

1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 SCOPE OF THE STUDY 34
1.3.1 MARKETS COVERED 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 34
1.4 CURRENCY 35
TABLE 1 STANDARD CURRENCY CONVERSION RATE 35
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH APPROACH 37
FIGURE 1 RESEARCH DESIGN 37
2.1.1 SECONDARY SOURCES 37
2.1.1.1 Key data from secondary sources 38
2.1.2 PRIMARY SOURCES 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
FIGURE 2 SUPPLY SIDE: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 41
FIGURE 4 MARKET SIZE ESTIMATION: PLASMA FRACTIONATION MARKET 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 5 DATA TRIANGULATION METHODOLOGY 44
2.4 MARKET SHARE ESTIMATION 45
FIGURE 6 ASSUMPTIONS FOR THE STUDY 45
FIGURE 7 LIMITATIONS OF THE STUDY 46
3 EXECUTIVE SUMMARY 47
FIGURE 8 PLASMA FRACTIONATION MARKET, BY PRODUCT,
2020 VS. 2025 (USD MILLION) 47
FIGURE 9 PLASMA FRACTIONATION MARKET, BY APPLICATION,
2020 VS. 2025 (USD MILLION) 48
FIGURE 10 PLASMA FRACTIONATION MARKET, BY END USER,
2020 VS. 2025 (USD MILLION) 48
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE PLASMA FRACTIONATION MARKET 49
4 PREMIUM INSIGHTS 50
4.1 PLASMA FRACTIONATION MARKET OVERVIEW 50
FIGURE 12 GROWING USE OF IMMUNOGLOBULINS IN VARIOUS THERAPEUTIC AREAS IS THE MAJOR FACTOR DRIVING MARKET GROWTH 50
4.2 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT & COUNTRY (2019) 51
FIGURE 13 IMMUNOGLOBULINS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PLASMA FRACTIONATION MARKET IN 2019 51
4.3 PLASMA FRACTIONATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 52
FIGURE 14 CHINA TO REGISTER THE HIGHEST CAGR IN THE PLASMA FRACTIONATION MARKET DURING THE FORECAST PERIOD 52
5 MARKET OVERVIEW 53
5.1 INTRODUCTION 53
5.2 MARKET DYNAMICS 53
TABLE 2 PLASMA FRACTIONATION MARKET: IMPACT ANALYSIS 53
5.2.1 MARKET DRIVERS 54
5.2.1.1 Growing use of immunoglobulins in various therapeutic areas 54
TABLE 3 ON-LABEL AND OFF-LABEL INDICATIONS OF IVIG 54
TABLE 4 NUMBER OF CLINICAL STUDIES ON IMMUNOGLOBULINS,
BY REGION (AS OF JULY 2020) 55
TABLE 5 NUMBER OF PATIENTS TREATED FOR TOP 10 TARGET CONDITIONS IN THE UK 55
5.2.1.2 Rising geriatric population 56
TABLE 6 GERIATRIC POPULATION, BY REGION, 2000−2050 56
5.2.1.3 Growing prevalence of respiratory diseases and AATD 57
FIGURE 15 GLOBAL PERCENTAGE OF DEATHS FROM RESPIRATORY DISEASES 57
5.2.2 MARKET RESTRAINTS 57
5.2.2.1 High cost and limited reimbursement 57
5.2.2.2 Emergence of recombinant alternatives 58
5.2.3 MARKET OPPORTUNITIES 58
5.2.3.1 Increased risk of pandemics and communicable diseases 58
5.2.3.2 Rising prevalence of bleeding disorders 59
FIGURE 16 NUMBER OF HEMOPHILIA A AND HEMOPHILIA B PATIENTS WORLDWIDE, 2012–2018 59
TABLE 7 NUMBER OF HEMOPHILIA PATIENTS IN DEVELOPED AND EMERGING COUNTRIES, 2016 VS. 2018 60
5.2.4 MARKET CHALLENGES 60
5.2.4.1 Stringent government regulations 60
6 INDUSTRY INSIGHTS 61
6.1 INTRODUCTION 61
6.2 KEY INDUSTRY TRENDS 61
6.2.1 FOCUS ON INCREASING FRACTIONATION CAPACITIES 61
TABLE 8 FRACTIONATION CAPACITY EXPANSIONS BY MAJOR PLAYERS 62
6.2.2 NEW INDICATIONS FOR PLASMA PRODUCTS 62
6.2.3 RISING ADOPTION OF SCIG 62
6.2.4 INCREASING NUMBER OF FRACTIONATOR-OWNED PLASMA COLLECTION CENTERS 63
6.2.5 GROWING PLASMA PRODUCTS MARKET IN CHINA 63
FIGURE 17 PLASMA FRACTIONATION MARKET IN CHINA VS. THE US, 2018–2025 64
TABLE 9 CHINA: TOP PLAYERS IN THE PLASMA FRACTIONATION MARKET, 2019 64
TABLE 10 MAJOR LOCAL PLAYERS IN CHINA 65
6.2.6 INCREASING FOCUS OF PLASMA FRACTIONATORS TOWARDS MANUFACTURING AND DEVELOPING RECOMBINANT FACTORS 65
TABLE 11 REGIONAL IMPACT ANALYSIS OF RECOMBINANT FACTORS ON PLASMA-DERIVED PRODUCTS 66
6.3 PORTER’S FIVE FORCES 67
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS 67
6.3.1 THREAT OF NEW ENTRANTS 67
6.3.2 THREAT OF SUBSTITUTES 68
6.3.3 BARGAINING POWER OF SUPPLIERS 68
6.3.4 BARGAINING POWER OF BUYERS 68
6.3.5 INTENSITY OF COMPETITIVE RIVALRY 69
6.4 VENDOR BENCHMARKING 69
6.4.1 PRODUCT PORTFOLIO ANALYSIS: PLASMA FRACTIONATION MARKET 69
6.4.2 NUMBER OF PLASMA COLLECTION CENTERS AND FRACTIONATION CAPACITIES, BY KEY PLAYER 71
6.4.3 BUSINESS PRESENCE OF KEY PLAYERS IN THE VALUE CHAIN 72
6.5 PRICING ANALYSIS 72
TABLE 12 AVERAGE SELLING PRICE OF PLASMA FRACTIONATION PRODUCTS,
BY PLAYER (2019) 72
TABLE 13 AVERAGE SELLING PRICE OF PLASMA FRACTIONATION PRODUCTS,
BY REGION (2019) 73
6.6 PLASMA COLLECTION 73
FIGURE 19 SOURCE PLASMA COLLECTION IN THE US, 2008–2019 74
FIGURE 20 PLASMA COLLECTION CENTERS IN THE US, 2005–2018 74
FIGURE 21 EUROPE: PLASMA COLLECTION, 2007–2019 75
TABLE 14 NUMBER OF PLASMA COLLECTION CENTERS, BY COMPANY, 2019 75
TABLE 15 PLASMA COLLECTION, BY REGION, 2018–2025 (MILLION LITER) 76
TABLE 16 NORTH AMERICA: PLASMA COLLECTION, BY COUNTRY,
2018–2025 (MILLION LITER) 76
6.7 IMPACT OF COVID-19 ON THE PLASMA FRACTIONATION MARKET 76
TABLE 17 COVID-19- CLINICAL TRIALS WITH KEY FINDINGS 77
TABLE 18 CLINICAL TRIALS OF CONVALESCENT PLASMA EXPECTED TO COMPLETE
THIS YEAR 77

7 PLASMA FRACTIONATION MARKET, BY PRODUCT 80
7.1 INTRODUCTION 81
TABLE 19 PLASMA FRACTIONATION MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 81
7.2 IMMUNOGLOBULINS 81
TABLE 20 IVIG VS. SCIG THERAPY 82
TABLE 21 IMMUNOGLOBULINS MARKET, BY TYPE, 2018–2025 (USD MILLION) 82
TABLE 22 IMMUNOGLOBULINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 83
7.2.1 INTRAVENOUS IMMUNOGLOBULINS 83
7.2.1.1 IVIg holds the largest share of the immunoglobulins market 83
TABLE 23 INTRAVENOUS IMMUNOGLOBULINS OFFERED BY KEY MARKET PLAYERS 84
TABLE 24 INTRAVENOUS IMMUNOGLOBULINS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 86
TABLE 25 INTRAVENOUS IMMUNOGLOBULINS MARKET, BY REGION,
2018–2025 (METRIC TONS) 87
7.2.2 SUBCUTANEOUS IMMUNOGLOBULINS 87
7.2.2.1 Benefit of self-administration and lower incidence of non-serious systemic adverse reactions will drive the growth of the SCIg market 87
TABLE 26 SUBCUTANEOUS IMMUNOGLOBULINS OFFERED BY KEY MARKET PLAYERS 88
TABLE 27 SUBCUTANEOUS IMMUNOGLOBULINS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 89
TABLE 28 SUBCUTANEOUS IMMUNOGLOBULINS MARKET, BY REGION,
2018–2025 (METRIC TONS) 90
7.2.3 OTHER IMMUNOGLOBULINS 90
TABLE 29 OTHER IMMUNOGLOBULINS OFFERED BY KEY MARKET PLAYERS 91
TABLE 30 OTHER IMMUNOGLOBULINS MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 93
TABLE 31 OTHER IMMUNOGLOBULINS MARKET, BY REGION,
2018–2025 (MILLION INTERNATIONAL UNITS) 94
7.3 COAGULATION FACTOR CONCENTRATES 94
TABLE 32 COAGULATION FACTOR CONCENTRATES MARKET, BY TYPE,
2018–2025 (USD MILLION) 95
TABLE 33 COAGULATION FACTOR CONCENTRATES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 96
7.3.1 FACTOR VIII 96
7.3.1.1 Factor VIII holds the largest share of the coagulation factor concentrates market 96
TABLE 34 FACTOR VIII OFFERED BY KEY MARKET PLAYERS 97
TABLE 35 FACTOR VIII MARKET, BY COUNTRY, 2018-2025 (USD MILLION) 98
TABLE 36 FACTOR VIII MARKET, BY REGION, 2018–2025
(MILLION INTERNATIONAL UNITS) 99
7.3.2 FACTOR IX 99
7.3.2.1 Rising number of hemophilic patients is expected to drive the growth of this market 99

TABLE 37 FACTOR IX OFFERED BY KEY MARKET PLAYERS 100
TABLE 38 FACTOR IX MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 101
TABLE 39 FACTOR IX MARKET, BY COUNTRY, 2018–2025
(MILLION INTERNATIONAL UNIT) 102
7.3.3 VON WILLEBRAND FACTOR 102
7.3.3.1 Market growth is primarily driven by the increasing prevalence and diagnosis of von Willebrand disease and hemophilia 102
TABLE 40 VON WILLEBRAND FACTOR OFFERED BY KEY MARKET PLAYERS 103
TABLE 41 VON WILLEBRAND FACTOR MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 104
TABLE 42 VON WILLEBRAND FACTOR MARKET, BY COUNTRY,
2018–2025 (MILLION INTERNATIONAL UNIT) 105
7.3.4 PROTHROMBIN COMPLEX CONCENTRATES 105
7.3.4.1 Advantages of PCC over fresh frozen plasma will support market growth in this segment 105
TABLE 43 PROTHROMBIN COMPLEX CONCENTRATES OFFERED BY KEY MARKET PLAYERS 106
TABLE 44 PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 107
TABLE 45 PROTHROMBIN COMPLEX CONCENTRATES MARKET, BY COUNTRY,
2018–2025 (MILLION INTERNATIONAL UNIT) 108
7.3.5 FIBRINOGEN CONCENTRATES 108
7.3.5.1 Safety profile, accuracy, and speed of administration are supporting the growth of the fibrinogen concentrates market 108
TABLE 46 FIBRINOGEN CONCENTRATES OFFERED BY KEY MARKET PLAYERS 109
TABLE 47 FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 109
TABLE 48 FIBRINOGEN CONCENTRATES MARKET, BY COUNTRY,
2018–2025 (MILLION INTERNATIONAL UNIT) 110
7.3.6 FACTOR XIII 110
7.3.6.1 Applications in treating rare bleeding disorders will contribute to the demand for factor XIII 110
TABLE 49 FACTOR XIII OFFERED BY KEY MARKET PLAYERS 111
TABLE 50 FACTOR XIII MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 111
TABLE 51 FACTOR XIII MARKET, BY COUNTRY, 2018–2025
(MILLION INTERNATIONAL UNIT) 112
7.4 ALBUMINS 112
7.4.1 RISING DEMAND FOR ALBUMIN AS AN ANTIOXIDANT TO DRIVE MARKET GROWTH 112
TABLE 52 ALBUMINS OFFERED BY KEY MARKET PLAYERS 113
TABLE 53 ALBUMINS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 114
TABLE 54 ALBUMINS MARKET, BY REGION, 2018–2025 (MILLION INTERNATIONAL UNIT) 115
7.5 PROTEASE INHIBITORS 115
7.5.1 RISING PREVALENCE OF COPD WILL DRIVE THE DEMAND FOR PROTEASE INHIBITORS 115
TABLE 55 PROTEASE INHIBITORS OFFERED BY KEY MARKET PLAYERS 116
TABLE 56 PROTEASE INHIBITORS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 117
TABLE 57 PROTEASE INHIBITORS MARKET, BY COUNTRY,
2018–2025 (MILLION INTERNATIONAL UNIT) 118
7.6 OTHER PRODUCTS 118
TABLE 58 OTHER PRODUCTS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 119
8 PLASMA FRACTIONATION MARKET, BY APPLICATION 120
8.1 INTRODUCTION 121
TABLE 59 PLASMA FRACTIONATION MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 121
8.2 NEUROLOGY 121
8.2.1 RISING PREVALENCE OF MAJOR AGE-RELATED NEUROLOGICAL DISORDERS TO DRIVE MARKET GROWTH 121
TABLE 60 NUMBER OF DALYS FOR NEUROLOGICAL DISORDERS AND THE PERCENTAGE OF DALYS PROJECTED FOR 2005, 2015, AND 2030 122
TABLE 61 PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN NEUROLOGY 123
TABLE 62 PLASMA FRACTIONATION MARKET FOR NEUROLOGY, BY COUNTRY,
2018–2025 (USD MILLION) 124
8.3 IMMUNOLOGY 124
8.3.1 INCREASING PREVALENCE OF IMMUNODEFICIENCY DISORDERS AMONG CHILDREN AND ADULTS TO DRIVE THE GROWTH OF THIS MARKET 124
TABLE 63 LIST OF FDA-APPROVED INDICATIONS FOR IMMUNOGLOBULINS IN IMMUNOLOGY 125
TABLE 64 DIAGNOSIS DISTRIBUTION OF DIFFERENT CATEGORIES OF PRIMARY IMMUNODEFICIENCY DISEASE 126
TABLE 65 PREVALENCE OF PRIMARY IMMUNODEFICIENCY DISEASE, BY REGION,
2013 VS. 2015 126
TABLE 66 PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN IMMUNOLOGY 127
TABLE 67 PLASMA FRACTIONATION MARKET FOR IMMUNOLOGY, BY COUNTRY,
2018–2025 (USD MILLION) 127
8.4 HEMATOLOGY 128
8.4.1 GROWTH IN THE NUMBER OF HEMOPHILIA PATIENTS TO DRIVE THE DEMAND FOR COAGULATION FACTOR CONCENTRATES AND IMMUNOGLOBULINS 128
TABLE 68 NUMBER OF HEMOPHILIA PATIENTS (2012–2018) 128
TABLE 69 PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN HEMATOLOGY 129
TABLE 70 PLASMA FRACTIONATION MARKET FOR HEMATOLOGY, BY COUNTRY,
2018–2025 (USD MILLION) 129
8.5 CRITICAL CARE 130
8.5.1 INCREASING OFF-LABEL USE OF ALBUMIN AND RISING USE OF ANTICOAGULANTS TO DRIVE THE DEMAND FOR PLASMA-DERIVED CRITICAL CARE PRODUCTS 130
TABLE 71 PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN CRITICAL CARE 130
TABLE 72 PLASMA FRACTIONATION MARKET FOR CRITICAL CARE, BY COUNTRY,
2018–2025 (USD MILLION) 131
8.6 PULMONOLOGY 131
8.6.1 RISING PREVALENCE OF ALPHA-1 ANTITRYPSIN DEFICIENCY AND COPD TO DRIVE THE PLASMA FRACTIONATION MARKET FOR PULMONOLOGY 131
TABLE 73 PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN PULMONOLOGY 132
TABLE 74 PLASMA FRACTIONATION MARKET FOR PULMONOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 132
8.7 HEMATO-ONCOLOGY 133
8.7.1 RISING NUMBER OF BLOOD CANCER PATIENTS TO DRIVE THE DEMAND FOR PLASMA-DERIVED PRODUCTS 133
TABLE 75 INCIDENCE OF LEUKEMIA, MULTIPLE MYELOMA, AND HODGKIN LYMPHOMA, BY REGION, 2012−2018 133
TABLE 76 PLASMA-DERIVED PRODUCTS AND THEIR APPLICATIONS IN HEMATO-ONCOLOGY 133
TABLE 77 PLASMA FRACTIONATION MARKET FOR HEMATO-ONCOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 134
8.8 RHEUMATOLOGY 134
8.8.1 INCREASING PREVALENCE OF RHEUMATIC CONDITIONS TO DRIVE THE PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY 134
TABLE 78 PLASMA FRACTIONATION MARKET FOR RHEUMATOLOGY, BY COUNTRY, 2018–2025 (USD MILLION) 135
8.9 OTHER APPLICATIONS 135
TABLE 79 PLASMA-DERIVED PRODUCTS FOR OTHER APPLICATIONS 136
TABLE 80 PLASMA FRACTIONATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION) 137
9 PLASMA FRACTIONATION MARKET, BY END USER 138
9.1 INTRODUCTION 139
TABLE 81 PLASMA FRACTIONATION MARKET, BY END USER,
2018–2025 (USD MILLION) 139
9.2 HOSPITALS & CLINICS 139
9.2.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND GROWTH IN THE NUMBER OF HOSPITALS & CLINICS—KEY FACTORS DRIVING GROWTH 139
TABLE 82 PLASMA FRACTIONATION MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2018–2025 (USD MILLION) 140
9.3 CLINICAL RESEARCH LABORATORIES 141
9.3.1 INCREASING NUMBER OF CLINICAL STUDIES ON NEW THERAPEUTIC INDICATIONS FOR PLASMA-DERIVED PRODUCTS TO DRIVE MARKET GROWTH 141
TABLE 83 CLINICAL STUDIES ON ALBUMIN & IMMUNOGLOBULIN, BY REGION (2017) 141
TABLE 84 PLASMA FRACTIONATION MARKET FOR CLINICAL RESEARCH LABORATORIES, BY COUNTRY, 2018–2025 (USD MILLION) 142
9.4 ACADEMIC INSTITUTES 142
9.4.1 GROWING DEMAND FOR NEW DRUG MOLECULES TO DRIVE THE DEMAND FOR PLASMA PRODUCTS IN ACADEMIC INSTITUTES 142
TABLE 85 PLASMA FRACTIONATION MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 143
10 PLASMA FRACTIONATION MARKET, BY REGION 144
10.1 INTRODUCTION 145
TABLE 86 PLASMA FRACTIONATION MARKET, BY REGION, 2018–2025 (USD MILLION) 145

10.2 NORTH AMERICA 146
FIGURE 22 NORTH AMERICA: PLASMA FRACTIONATION MARKET SNAPSHOT 146
TABLE 87 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 147
TABLE 88 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 147
TABLE 89 NORTH AMERICA: IMMUNOGLOBULINS MARKET, BY TYPE,
2018–2025 (USD MILLION) 147
TABLE 90 NORTH AMERICA: COAGULATION FACTOR CONCENTRATES MARKET, BY TYPE, 2018–2025 (USD MILLION) 148
TABLE 91 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 148
TABLE 92 NORTH AMERICA: PLASMA FRACTIONATION MARKET, BY END USER,
2018–2025 (USD MILLION) 148
10.2.1 US 149
10.2.1.1 The US dominates the global plasma fractionation market 149
TABLE 93 US: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 149
TABLE 94 US: IMMUNOGLOBULINS MARKET, BY TYPE, 2018–2025 (USD MILLION) 150
TABLE 95 US: COAGULATION FACTOR CONCENTRATES MARKET, BY TYPE,
2018–2025 (USD MILLION) 150
TABLE 96 US: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 150
TABLE 97 US: PLASMA FRACTIONATION MARKET, BY END USER,
2018–2025 (USD MILLION) 151
10.2.2 CANADA 151
10.2.2.1 Canada is among the world’s highest per capita users of IVIg 151
TABLE 98 CANADA: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 152
TABLE 99 CANADA: IMMUNOGLOBULINS MARKET, BY TYPE,
2018–2025 (USD MILLION) 152
TABLE 100 CANADA: COAGULATION FACTOR CONCENTRATES MARKET, BY TYPE,
2018–2025 (USD MILLION) 152
TABLE 101 CANADA: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 153
TABLE 102 CANADA: PLASMA FRACTIONATION MARKET, BY END USER,
2018–2025 (USD MILLION) 153
10.3 EUROPE 153
TABLE 103 PLASMA FRACTIONATION PLANTS IN EUROPE (2017) 154
TABLE 104 EUROPE: PLASMA FRACTIONATION MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 155
TABLE 105 EUROPE: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 155
TABLE 106 EUROPE: IMMUNOGLOBULINS MARKET, BY TYPE,
2018–2025 (USD MILLION) 155
TABLE 107 EUROPE: COAGULATION FACTOR CONCENTRATES MARKET, BY TYPE,
2018–2025 (USD MILLION) 156
TABLE 108 EUROPE: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 156
TABLE 109 EUROPE: PLASMA FRACTIONATION MARKET, BY END USER,
2018–2025 (USD MILLION) 156
10.3.1 GERMANY 157
10.3.1.1 Germany has the highest plasma fractionation capacity in Europe 157
TABLE 110 GERMANY: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 157
TABLE 111 GERMANY: IMMUNOGLOBULINS MARKET, BY TYPE,
2018–2025 (USD MILLION) 158
TABLE 112 GERMANY: COAGULATION FACTOR CONCENTRATES MARKET, BY TYPE, 2018–2025 (USD MILLION) 158
TABLE 113 GERMANY: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 158
TABLE 114 GERMANY: PLASMA FRACTIONATION MARKET, BY END USER,
2018–2025 (USD MILLION) 159
10.3.2 FRANCE 159
10.3.2.1 High prevalence of bleeding disorders to drive the market for plasma fractionation in France 159
TABLE 115 NUMBER OF PEOPLE WITH BLEEDING DISORDERS IN FRANCE, 2012–2018 159
TABLE 116 FRANCE: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 160
TABLE 117 FRANCE: IMMUNOGLOBULINS MARKET, BY TYPE,
2018–2025 (USD MILLION) 160
TABLE 118 FRANCE: COAGULATION FACTOR CONCENTRATES MARKET, BY TYPE,
2018–2025 (USD MILLION) 161
TABLE 119 FRANCE: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 161
TABLE 120 FRANCE: PLASMA FRACTIONATION MARKET, BY END USER,
2018–2025 (USD MILLION) 161
10.3.3 ITALY 162
10.3.3.1 Growth in the country’s geriatric population to drive the market for plasma fractionation 162
TABLE 121 PRODUCTION OF PLASMA PRODUCTS IN ITALY (2013, 2018-E, & 2023-E) 162
TABLE 122 ITALY: PLASMA FRACTIONATION MARKET, BY PRODUCT,
2018–2025 (USD MILLION) 163
TABLE 123 ITALY: IMMUNOGLOBULINS MARKET, BY TYPE, 2018–2025 (USD MILLION) 163
TABLE 124 ITALY: COAGULATION FACTOR CONCENTRATES MARKET, BY TYPE,
2018–2025 (USD MILLION) 163
TABLE 125 ITALY: PLASMA FRACTIONATION MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 164
TABLE 126 ITALY: PLASMA FRACTIONATION MARKET, BY END USER,
2018–2025 (USD MILLION) 164

13.6.3 CHINA 209
13.6.3.1 Rising demand for ammunition procurement due to geopolitical tensions with neighboring countries 209
FIGURE 55 CHINA: MILITARY SPENDING, 2010–2019 (USD BILLION) 209
TABLE 183 CHINA AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 210
TABLE 184 CHINA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 210
TABLE 185 CHINA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 210
TABLE 186 CHINA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 210
TABLE 187 CHINA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 211
TABLE 188 CHINA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 211
TABLE 189 CHINA AMMUNITION MARKET SIZE, BY CALIBER, 2016–2019 (USD MILLION) 211
TABLE 190 CHINA AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 211
TABLE 191 CHINA SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY, BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 212
13.6.4 INDIA 212
13.6.4.1 Increasing defense budgets of the country to drive market growth for ammunition in India 212
FIGURE 56 INDIA: MILITARY SPENDING, 2010–2019 (USD BILLION) 212
TABLE 192 INDIA AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 213
TABLE 193 INDIA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 213
TABLE 194 INDIA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 213
TABLE 195 INDIA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 213
TABLE 196 INDIA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 214
TABLE 197 INDIA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 214
TABLE 198 INDIA AMMUNITION MARKET SIZE, BY CALIBER, 2016–2019 (USD MILLION) 214
TABLE 199 INDIA AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 214
TABLE 200 INDIA SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY, BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 215
13.6.5 JAPAN 215
13.6.5.1 Development of high-end indigenous ammunition technology drives the market growth in Japan 215
FIGURE 57 JAPAN: MILITARY SPENDING, 2010–2019 (USD BILLION) 215
TABLE 201 JAPAN AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 216
TABLE 202 JAPAN AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 216
TABLE 203 JAPAN AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 216
TABLE 204 JAPAN AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 216
TABLE 205 JAPAN AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 217
TABLE 206 JAPAN AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 217
TABLE 207 JAPAN AMMUNITION MARKET SIZE, BY CALIBER, 2016–2019 (USD MILLION) 217
TABLE 208 JAPAN AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 217
TABLE 209 JAPAN SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY,
BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 218
13.6.6 SOUTH KOREA 218
13.6.6.1 Increasing demand for ammunition for use in advanced MBTs and IFVs supports market growth in South Korea 218
FIGURE 58 SOUTH KOREA: MILITARY SPENDING, 2010–2019 (USD BILLION) 218
TABLE 210 SOUTH KOREA AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 219
TABLE 211 SOUTH KOREA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 219
TABLE 212 SOUTH KOREA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 219
TABLE 213 SOUTH KOREA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 219
TABLE 214 SOUTH KOREA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2016–2019 (USD MILLION) 220
TABLE 215 SOUTH KOREA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2020–2025 (USD MILLION) 220
TABLE 216 SOUTH KOREA AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 220
TABLE 217 SOUTH KOREA AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 220
TABLE 218 SOUTH KOREA SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY, BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 221
13.6.7 AUSTRALIA 221
13.6.7.1 Rising demand for advanced ammunition by defense forces drives the market growth 221
FIGURE 59 AUSTRALIA: MILITARY SPENDING, 2010–2019 (USD BILLION) 221
TABLE 219 AUSTRALIA AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 222
TABLE 220 AUSTRALIA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 222
TABLE 221 AUSTRALIA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 222
TABLE 222 AUSTRALIA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 222
TABLE 223 AUSTRALIA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 223
TABLE 224 AUSTRALIA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 223
TABLE 225 AUSTRALIA AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 223
TABLE 226 AUSTRALIA AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 223
TABLE 227 AUSTRALIA SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY,
BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 224
13.6.8 SINGAPORE 224
13.6.8.1 Rising demand for ammunition from law enforcement agencies drives the market growth in Singapore 224
TABLE 228 SINGAPORE AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 224
TABLE 229 SINGAPORE AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 224
TABLE 230 SINGAPORE AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 225
TABLE 231 SINGAPORE AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 225
TABLE 232 SINGAPORE AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 225
TABLE 233 SINGAPORE AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 225
TABLE 234 SINGAPORE AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 226
TABLE 235 SINGAPORE AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 226
TABLE 236 SINGAPORE SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY,
BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 226
13.6.9 INDONESIA 226
13.6.9.1 Indonesia is a fast-growing defense market in the APAC region 226
FIGURE 60 INDONESIA: MILITARY SPENDING, 2010–2019 (USD MILLION) 227
TABLE 237 INDONESIA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 227
TABLE 238 INDONESIA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 227
TABLE 239 INDONESIA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 228
TABLE 240 INDONESIA AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 228
TABLE 241 INDONESIA SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY,
BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 228
13.6.10 VIETNAM 229
13.6.10.1 Rising tensions between Vietnam and other countries have led to increasing military capabilities, thus supporting market growth 229
TABLE 242 VIETNAM AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 229
TABLE 243 VIETNAM AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 229
TABLE 244 VIETNAM AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2020–2025 (USD MILLION) 229
TABLE 245 VIETNAM AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 230
TABLE 246 VIETNAM SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY,
BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 230
13.6.11 REST OF ASIA PACIFIC 230
FIGURE 61 MALAYSIA: MILITARY SPENDING, 2010–2019 (USD MILLION) 231
FIGURE 62 NEW ZEALAND: MILITARY SPENDING, 2010–2019 (USD MILLION) 231
FIGURE 63 PHILIPPINES: MILITARY SPENDING, 2010–2019 (USD MILLION) 232
FIGURE 64 TAIWAN: MILITARY SPENDING, 2010–2019 (USD MILLION) 232
TABLE 247 REST OF ASIA PACIFIC AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 232
TABLE 248 REST OF ASIA PACIFIC AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 233
TABLE 249 REST OF ASIA PACIFIC AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE, 2016–2019 (USD MILLION) 233
TABLE 250 REST OF ASIA PACIFIC AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE, 2020–2025 (USD MILLION) 233
TABLE 251 REST OF ASIA PACIFIC AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 233
TABLE 252 REST OF ASIA PACIFIC AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 234
TABLE 253 REST OF ASIA PACIFIC AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 234
TABLE 254 REST OF ASIA PACIFIC AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 234
13.7 MIDDLE EAST 235
13.7.1 COVID-19 IMPACT ON THE MIDDLE EAST 235
13.7.2 PESTLE ANALYSIS: MIDDLE EAST 236
FIGURE 65 MIDDLE EAST AMMUNITION MARKET SNAPSHOT: ISRAEL TO HAVE THE HIGHEST GROWTH POTENTIAL DURING THE FORECAST PERIOD 237
TABLE 255 MIDDLE EAST AMMUNITION MARKET SIZE, BY COUNTRY,
2016–2019 (USD MILLION) 237
TABLE 256 MIDDLE EAST AMMUNITION MARKET SIZE, BY COUNTRY,
2020–2025 (USD MILLION) 238
TABLE 257 MIDDLE EAST AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 238
TABLE 258 MIDDLE EAST AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 238
TABLE 259 MIDDLE EAST AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 238
TABLE 260 MIDDLE EAST AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 239
TABLE 261 MIDDLE EAST AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2016–2019 (USD MILLION) 239
TABLE 262 MIDDLE EAST AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2020–2025 (USD MILLION) 239
TABLE 263 MIDDLE EAST AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 239
TABLE 264 MIDDLE EAST AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 240
TABLE 265 MIDDLE EAST SMALL CALIBER AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 240
TABLE 266 MIDDLE EAST MEDIUM CALIBER AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 240
TABLE 267 MIDDLE EAST LARGE CALIBER AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 241
TABLE 268 MIDDLE EAST AMMUNITION MARKET SIZE, BY PRODUCT,
2016–2019 (USD MILLION) 241
TABLE 269 MIDDLE EAST AMMUNITION MARKET SIZE, BY PRODUCT,
2020–2025 (USD MILLION) 241
TABLE 270 MIDDLE EAST AMMUNITION MARKET SIZE, BY COMPONENT,
2016–2019 (USD MILLION) 242
TABLE 271 MIDDLE EAST AMMUNITION MARKET SIZE, BY COMPONENT,
2020–2025 (USD MILLION) 242
TABLE 272 MIDDLE EAST AMMUNITION MARKET SIZE, BY GUIDANCE,
2016–2019 (USD MILLION) 242
TABLE 273 MIDDLE EAST AMMUNITION MARKET SIZE, BY GUIDANCE,
2020–2025 (USD MILLION) 242
TABLE 274 MIDDLE EAST AMMUNITION MARKET SIZE, BY LETHALITY,
2016–2019 (USD MILLION) 243
TABLE 275 MIDDLE EAST AMMUNITION MARKET SIZE, BY LETHALITY,
2020–2025 (USD MILLION) 243
13.7.3 SAUDI ARABIA 243
13.7.3.1 Increased procurement of ammunition in Saudi Arabia drives the market growth 243
FIGURE 66 SAUDI ARABIA: MILITARY SPENDING, 2010–2019 (USD BILLION) 244
TABLE 276 SAUDI ARABIA AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 244
TABLE 277 SAUDI ARABIA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 244
TABLE 278 SAUDI ARABIA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 244
TABLE 279 SAUDI ARABIA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 245
TABLE 280 SAUDI ARABIA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2016–2019 (USD MILLION) 245
TABLE 281 SAUDI ARABIA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2020–2025 (USD MILLION) 245
TABLE 282 SAUDI ARABIA AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 245
TABLE 283 SAUDI ARABIA AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 246
TABLE 284 SAUDI ARABIA SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY, BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 246

13.7.4 TURKEY 246
13.7.4.1 Turkey increasing focus strengthening its armed forces to lead to the growth of the ammunition market in the country 246
FIGURE 67 TURKEY: MILITARY SPENDING, 2010–2019 (USD BILLION) 247
TABLE 285 TURKEY AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 247
TABLE 286 TURKEY AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 247
TABLE 287 TURKEY AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 247
TABLE 288 TURKEY AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 248
TABLE 289 TURKEY AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 248
TABLE 290 TURKEY AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 248
TABLE 291 TURKEY AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 248
TABLE 292 TURKEY AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 249
TABLE 293 TURKEY SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY,
BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 249
13.7.5 ISRAEL 249
13.7.5.1 High adoption of advanced weapon systems in Israel in the past few years leading to the growth of the ammunition market in the country 249
FIGURE 68 ISRAEL: MILITARY SPENDING, 2010–2019 (USD BILLION) 250
TABLE 294 ISRAEL AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 250
TABLE 295 ISRAEL AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 250
TABLE 296 ISRAEL AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 250
TABLE 297 ISRAEL AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 251
TABLE 298 ISRAEL AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 251
TABLE 299 ISRAEL AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 251
TABLE 300 ISRAEL AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 251
TABLE 301 ISRAEL AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 252
TABLE 302 ISRAEL SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY, BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 252

13.7.6 UAE 252
13.7.6.1 Rising territorial disputes in the region leading to operational readiness of the country’s defense forces 252
FIGURE 69 UAE: MILITARY SPENDING, 2010-2014 (USD MILLION) 253
TABLE 303 UAE AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 253
TABLE 304 UAE AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 253
TABLE 305 UAE AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE,
2020–2025 (USD MILLION) 254
TABLE 306 UAE AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 254
TABLE 307 UAE SMALL CALIBER AMMUNITION MARKET SIZE FOR MILITARY,
BY NATO GRADE CALIBER, 2020–2025 (USD MILLION) 254
13.7.7 REST OF MIDDLE EAST 255
FIGURE 70 JORDAN: MILITARY SPENDING, 2010–2019 (USD MILLION) 255
FIGURE 71 KUWAIT: MILITARY SPENDING, 2010–2019 (USD MILLION) 255
FIGURE 72 OMAN: MILITARY SPENDING, 2010–2019 (USD MILLION) 256
TABLE 308 REST OF MIDDLE EAST AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 256
TABLE 309 REST OF MIDDLE EAST AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 256
TABLE 310 REST OF MIDDLE EAST AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE, 2016–2019 (USD MILLION) 256
TABLE 311 REST OF MIDDLE EAST AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE, 2020–2025 (USD MILLION) 257
TABLE 312 REST OF MIDDLE EAST AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 257
TABLE 313 REST OF MIDDLE EAST AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 257
TABLE 314 REST OF MIDDLE EAST AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 257
TABLE 315 REST OF MIDDLE EAST AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 258
13.8 LATIN AMERICA 258
13.8.1 COVID-19 IMPACT ON LATIN AMERICA 258
13.8.2 PESTLE ANALYSIS: LATIN AMERICA 259
TABLE 316 LATIN AMERICA AMMUNITION MARKET SIZE, BY COUNTRY,
2020–2025 (USD MILLION) 259
TABLE 317 LATIN AMERICA AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 260
TABLE 318 LATIN AMERICA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 260
TABLE 319 LATIN AMERICA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 260
TABLE 320 LATIN AMERICA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 260
TABLE 321 LATIN AMERICA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2016–2019 (USD MILLION) 261
TABLE 322 LATIN AMERICA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2020–2025 (USD MILLION) 261
TABLE 323 LATIN AMERICA AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 261
TABLE 324 LATIN AMERICA AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 261
TABLE 325 LATIN AMERICA SMALL CALIBER AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 262
TABLE 326 LATIN AMERICA MEDIUM CALIBER AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 262
TABLE 327 LATIN AMERICA LARGE CALIBER AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 262
TABLE 328 LATIN AMERICA AMMUNITION MARKET SIZE, BY PRODUCT,
2016–2019 (USD MILLION) 263
TABLE 329 LATIN AMERICA AMMUNITION MARKET SIZE, BY PRODUCT,
2020–2025 (USD MILLION) 263
TABLE 330 LATIN AMERICA AMMUNITION MARKET SIZE, BY COMPONENT,
2016–2019 (USD MILLION) 263
TABLE 331 LATIN AMERICA AMMUNITION MARKET SIZE, BY COMPONENT,
2020–2025 (USD MILLION) 264
TABLE 332 LATIN AMERICA AMMUNITION MARKET SIZE, BY GUIDANCE,
2016–2019 (USD MILLION) 264
TABLE 333 LATIN AMERICA AMMUNITION MARKET SIZE, BY GUIDANCE,
2020–2025 (USD MILLION) 264
TABLE 334 LATIN AMERICA AMMUNITION MARKET SIZE, BY LETHALITY,
2016–2019 (USD MILLION) 264
TABLE 335 LATIN AMERICA AMMUNITION MARKET SIZE, BY LETHALITY,
2020–2025 (USD MILLION) 265
13.8.3 BRAZIL 265
13.8.3.1 Increasing focus on modernization of armed forces to support market growth in the coming years 265
FIGURE 73 BRAZIL: MILITARY SPENDING, 2010–2019 (USD BILLION) 265
TABLE 336 BRAZIL AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 266
TABLE 337 BRAZIL AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 266
TABLE 338 BRAZIL AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 266
TABLE 339 BRAZIL AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 266
13.8.4 ARGENTINA 267
13.8.4.1 Rising demand for ammunition due to modernization of armed forces 267
FIGURE 74 ARGENTINA: MILITARY SPENDING, 2010–2019 (USD MILLION) 267
TABLE 340 ARGENTINA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 267
TABLE 341 ARGENTINA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 268
TABLE 342 ARGENTINA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 268
TABLE 343 ARGENTINA AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 268
13.8.5 MEXICO 268
13.8.5.1 Presence of drug cartels and increasing drug trafficking activities lead to the rising demand for small caliber ammunition in Mexico 268
FIGURE 75 MEXICO: MILITARY SPENDING, 2010–2019 (USD BILLION) 269
TABLE 344 MEXICO AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 269
TABLE 345 MEXICO AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 269
TABLE 346 MEXICO AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2020–2025 (USD MILLION) 270
TABLE 347 MEXICO AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 270
13.9 AFRICA 270
13.9.1 COVID-19 IMPACT ON AFRICA 270
13.9.2 PESTLE ANALYSIS: AFRICA 271
TABLE 348 AFRICA AMMUNITION MARKET SIZE, BY COUNTRY,
2020–2025 (USD MILLION) 271
TABLE 349 AFRICA AMMUNITION MARKET SIZE, BY APPLICATION,
2016–2019 (USD MILLION) 271
TABLE 350 AFRICA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 272
TABLE 351 AFRICA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2016–2019 (USD MILLION) 272
TABLE 352 AFRICA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 272
TABLE 353 AFRICA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2016–2019 (USD MILLION) 272
TABLE 354 AFRICA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 273
TABLE 355 AFRICA AMMUNITION MARKET SIZE, BY CALIBER,
2016–2019 (USD MILLION) 273
TABLE 356 AFRICA AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 273
TABLE 357 AFRICA SMALL CALIBER AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 274
TABLE 358 AFRICA MEDIUM CALIBER AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 274
TABLE 359 AFRICA LARGE CALIBER AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 274
TABLE 360 AFRICA AMMUNITION MARKET SIZE, BY PRODUCT,
2016–2019 (USD MILLION) 275
TABLE 361 AFRICA AMMUNITION MARKET SIZE, BY PRODUCT,
2020–2025 (USD MILLION) 275
TABLE 362 AFRICA AMMUNITION MARKET SIZE, BY COMPONENT,
2016–2019 (USD MILLION) 275
TABLE 363 AFRICA AMMUNITION MARKET SIZE, BY COMPONENT,
2020–2025 (USD MILLION) 276
TABLE 364 AFRICA AMMUNITION MARKET SIZE, BY GUIDANCE,
2016–2019 (USD MILLION) 276
TABLE 365 AFRICA AMMUNITION MARKET SIZE, BY GUIDANCE,
2020–2025 (USD MILLION) 276
TABLE 366 AFRICA AMMUNITION MARKET SIZE, BY LETHALITY,
2016–2019 (USD MILLION) 276
TABLE 367 AFRICA AMMUNITION MARKET SIZE, BY LETHALITY
, 2020–2025 (USD MILLION) 277
13.9.3 SOUTH AFRICA 277
13.9.3.1 Replacement of aging military equipment to drive market growth 277
FIGURE 76 SOUTH AFRICA: MILITARY SPENDING, 2010–2019 (USD MILLION) 277
TABLE 368 SOUTH AFRICA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 277
TABLE 369 SOUTH AFRICA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 278
TABLE 370 SOUTH AFRICA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL,
BY TYPE, 2020–2025 (USD MILLION) 278
TABLE 371 SOUTH AFRICA AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 278
13.9.4 EGYPT 278
13.9.4.1 The increased focus on multilateral training exercises to strengthen its armed forces drives the market growth in Egypt 278
FIGURE 77 EGYPT: MILITARY SPENDING, 2010–2019 (USD MILLION) 279
TABLE 372 EGYPT AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 279
TABLE 373 EGYPT AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 279
TABLE 374 EGYPT AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 279
TABLE 375 EGYPT AMMUNITION MARKET SIZE, BY CALIBER, 2020–2025 (USD MILLION) 280
13.9.5 ALGERIA 280
13.9.5.1 Rising threats from terrorist groups and instability with neighboring countries to support market growth 280
FIGURE 78 ALGERIA: MILITARY SPENDING, 2010–2019 (USD MILLION) 280
TABLE 376 ALGERIA AMMUNITION MARKET SIZE, BY APPLICATION,
2020–2025 (USD MILLION) 281
TABLE 377 ALGERIA AMMUNITION MARKET SIZE FOR DEFENSE, BY TYPE,
2020–2025 (USD MILLION) 281
TABLE 378 ALGERIA AMMUNITION MARKET SIZE FOR CIVIL & COMMERCIAL, BY TYPE, 2020–2025 (USD MILLION) 281
TABLE 379 ALGERIA AMMUNITION MARKET SIZE, BY CALIBER,
2020–2025 (USD MILLION) 281

14 COMPANY LANDSCAPE 282
14.1 INTRODUCTION 282
FIGURE 79 KEY MARKET PLAYERS ADOPTED CONTRACTS AS THE KEY GROWTH STRATEGY FROM 2017 TO JULY 2020 283
14.2 COMPANY RANK ANALYSIS, 2019 284
FIGURE 80 COMPANY RANKING ANALYSIS 2019 284
14.3 MARKET SHARE ANALYSIS 2019 285
FIGURE 81 MARKET SHARE ANALYSIS 2019 285
14.4 COMPETITIVE SITUATIONS AND TRENDS 285
14.4.1 MARKET EVALUATION FRAMEWORK 286
FIGURE 82 MARKET EVALUATION FRAMEWORK: CONTRACTS OBSERVED TO BE LEADING STRATEGIES AMONG TOP PLAYERS IN 2020 286
14.4.2 CONTRACTS 286
TABLE 380 CONTRACTS (2017–JULY 2020) 286
14.4.3 NEW PRODUCT LAUNCHES AND NEW PRODUCT DEVELOPMENTS 291
TABLE 381 NEW PRODUCT LAUNCHES AND NEW PRODUCT DEVELOPMENTS
(2017-JULY 2020) 291
14.4.4 JOINT VENTURES, PARTNERSHIPS, AND ACQUISITIONS 292
TABLE 382 JOINT VENTURES, PARTNERSHIPS, AND ACQUISITIONS
(2017 AND JULY 2020) 292
14.4.5 AGREEMENTS AND EXPANSIONS 294
TABLE 383 AGREEMENTS AND EXPANSIONS (2017–JULY 2020) 294
15 COMPANY EVALUATION MATRIX AND COMPANY PROFILES 296
15.1 COMPANY EVALUATION MATRIX 296
15.1.1 STAR 296
15.1.2 EMERGING LEADERS 296
15.1.3 PERVASIVE 296
15.1.4 EMERGING COMPANIES 296
FIGURE 83 AMMUNITION COMPANY EVALUATION MATRIX, 2019 297
(on Business Overview, Products/Services/Solutions Offered, Growth Strategies (Organic & Inorganic), Recent Developments, SWOT Analysis, and MnM View)*
15.2 AMMO INCORPORATED 298
FIGURE 84 AMMO INCORPORATED: COMPANY SNAPSHOT 298
15.3 ARSENAL JSCO. 302
15.4 BAE SYSTEMS 304
FIGURE 85 BAE SYSTEMS: COMPANY SNAPSHOT 304
FIGURE 86 BAE SYSTEMS: SWOT ANALYSIS 307
15.5 CBC GLOBAL AMMUNITION 308
15.6 CHEMRING GROUP PLC 311
FIGURE 87 CHEMRING GROUP PLC: COMPANY SNAPSHOT 311
15.7 DENEL SOC LTD. 314
FIGURE 88 DENEL SOC LTD.: COMPANY SNAPSHOT 314
15.8 ELBIT SYSTEMS LTD. 317
FIGURE 89 ELBIT SYSTEMS LTD.: COMPANY SNAPSHOT 317
15.9 FIOCCHI MUNIZIONI SPA 320
15.10 GENERAL DYNAMICS CORPORATION 322
FIGURE 90 GENERAL DYNAMICS CORPORATION: COMPANY SNAPSHOT 323
FIGURE 91 GENERAL DYNAMICS CORPORATION: SWOT ANALYSIS 325
15.11 HANWHA CORPORATION 326
FIGURE 92 HANWHA CORPORATION: COMPANY SNAPSHOT 326
15.12 HERSTAL GROUP (FN HERSTAL) 328
15.13 HORNADY 329
15.14 MAXAM (EXPAL) 332
FIGURE 93 MAXAM (EXPAL): COMPANY SNAPSHOT 332
15.15 NAMMO AS 336
FIGURE 94 NAMMO AS: COMPANY SNAPSHOT 336
FIGURE 95 NAMMO AS: SWOT ANALYSIS 339
15.16 NEXTER 340
15.17 NORINCO 343
15.18 NORTHROP GRUMMAN CORPORATION 344
FIGURE 96 NORTHROP GRUMMAN CORPORATION: COMPANY SNAPSHOT 344
FIGURE 97 NORTHROP GRUMMAN: SWOT ANALYSIS 347
15.19 OLIN CORPORATION 348
FIGURE 98 OLIN CORPORATION: COMPANY SNAPSHOT 348
FIGURE 99 OLIN CORPORATION: SWOT ANALYSIS 353
15.20 POONGSAN CORPORATION 355
FIGURE 100 POONGSAN CORPORATION: COMPANY SNAPSHOT 355
15.21 RUAG GROUP (RUAG AMMOTEC) 357
FIGURE 101 RUAG GROUP: COMPANY SNAPSHOT 357
15.22 REMINGTON OUTDOOR COMPANY 360
FIGURE 102 REMINGTON OUTDOOR COMPANY: COMPANY SNAPSHOT 360
15.23 RHEINMETALL AG 361
FIGURE 103 RHEINMETALL AG: COMPANY SNAPSHOT 361
15.24 ROSOBORONEXPORT 364
15.25 SIERRA BULLETS 366
15.26 SIG SAUER 367
15.27 ST ENGINEERING 369
FIGURE 104 ST ENGINEERING: COMPANY SNAPSHOT 369
15.28 THALES GROUP 372
FIGURE 105 THALES GROUP: COMPANY SNAPSHOT 372
FIGURE 106 THALES GROUP: SWOT ANALYSIS 374
15.29 VISTA OUTDOOR INC. 376
FIGURE 107 VISTA OUTDOOR INC.: COMPANY SNAPSHOT 376
15.30 YUGOIMPORT-SDPR J.P. 379
*Details on Business Overview, Products/Services/Solutions Offered, Growth Strategies (Organic & Inorganic), Recent Developments, SWOT Analysis, and MnM View might not be captured in case of unlisted companies.
16 AMMUNITION ADJACENT MARKETS 381
16.1 PRECISION GUIDED MUNITIONS MARKET 381
16.1.1 INTRODUCTION 381
16.1.2 PRECISION GUIDED MUNITIONS, BY PRODUCT 381
TABLE 384 PRECISION GUIDED MUNITION MARKET SIZE, BY PRODUCT,
2017–2025 (USD MILLION) 381
16.1.3 PRECISION GUIDED MUNITIONS, BY TECHNOLOGY 381
TABLE 385 PRECISION GUIDED MUNITION MARKET SIZE, BY TECHNOLOGY,
2017–2025 (USD MILLION) 382
16.1.4 PRECISION GUIDED MUNITIONS, BY TYPE 382
TABLE 386 PRECISION GUIDED MUNITION MARKET SIZE, BY TYPE,
2017–2025 (USD MILLION) 382
16.1.5 PRECISION GUIDED MUNITIONS, BY SPEED 382
16.2 ROCKETS AND MISSILES MARKET 383
16.2.1 INTRODUCTION 383
16.2.2 ROCKETS AND MISSILES MARKET, BY TYPE 383
TABLE 387 ROCKET AND MISSILE MARKET SIZE, BY TYPE, 2015-2022 (USD BILLION) 383
16.2.3 ROCKETS AND MISSILES MARKET, BY LAUNCH MODE 383
TABLE 388 ROCKET AND MISSILE MARKET SIZE, BY LAUNCH MODE,
2015-2022 (USD BILLION) 384
16.2.4 ROCKETS AND MISSILES MARKET, BY PROPULSION 384
TABLE 389 ROCKET AND MISSILE MARKET SIZE, BY PROPULSION,
2015-2022 (USD BILLION) 384
16.3 LESS LETHAL AMMUNITION MARKET 385
16.3.1 INTRODUCTION 385
16.3.2 LESS LETHAL AMMUNITION MARKET, BY END USER 385
TABLE 390 LESS LETHAL AMMUNITION MARKET, BY END USER,
2016–2023 (USD MILLION) 385
16.3.3 LESS LETHAL AMMUNITION MARKET, BY PRODUCT 385
TABLE 391 LESS LETHAL AMMUNITION MARKET, BY PRODUCT,
2016–2023 (USD MILLION) 386
16.3.4 LESS LETHAL AMMUNITION MARKET, BY WEAPON TYPE 386
TABLE 392 LESS LETHAL AMMUNITION MARKET, BY WEAPON TYPE,
2016–2023 (USD MILLION) 386
17 APPENDIX 387
17.1 DISCUSSION GUIDE 387
17.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 390
17.3 AVAILABLE CUSTOMIZATIONS 392
17.4 RELATED REPORTS 392
17.5 AUTHOR DETAILS 393

★調査レポート[血漿分画の世界市場予測(〜2025):製品別(IVIG、アルブミン、第VIII因子、フォンウィルブランド因子、PCC、プロテアーゼ阻害剤)、用途別(免疫学、血液学、クリティカルケア、リウマチ学、呼吸器学)、エンドユーザー別(病院、診療所)] ( Plasma Fractionation Market by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Hematology, Critical Care, Rheumatology, Pulmonology), End User (Hospitals & Clinics) - Global Forecast to 2025 / BT 3042) 販売に関する免責事項
[血漿分画の世界市場予測(〜2025):製品別(IVIG、アルブミン、第VIII因子、フォンウィルブランド因子、PCC、プロテアーゼ阻害剤)、用途別(免疫学、血液学、クリティカルケア、リウマチ学、呼吸器学)、エンドユーザー別(病院、診療所)] ( Plasma Fractionation Market by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Hematology, Critical Care, Rheumatology, Pulmonology), End User (Hospitals & Clinics) - Global Forecast to 2025 / BT 3042) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆